Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease.
Publication
, Journal Article
Despa, F; Goldstein, LB; Biessels, GJ
Published in: Ann Neurol
March 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Neurol
DOI
EISSN
1531-8249
Publication Date
March 2020
Volume
87
Issue
3
Start / End Page
486
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Islet Amyloid Polypeptide
- Humans
- Diabetes Mellitus, Type 2
- Brain
- Amyloid
- Alzheimer Disease
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Despa, F., Goldstein, L. B., & Biessels, G. J. (2020). Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease. Ann Neurol, 87(3), 486. https://doi.org/10.1002/ana.25668
Despa, Florin, Larry B. Goldstein, and Geert Jan Biessels. “Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease.” Ann Neurol 87, no. 3 (March 2020): 486. https://doi.org/10.1002/ana.25668.
Despa F, Goldstein LB, Biessels GJ. Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease. Ann Neurol. 2020 Mar;87(3):486.
Despa, Florin, et al. “Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease.” Ann Neurol, vol. 87, no. 3, Mar. 2020, p. 486. Pubmed, doi:10.1002/ana.25668.
Despa F, Goldstein LB, Biessels GJ. Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease. Ann Neurol. 2020 Mar;87(3):486.
Published In
Ann Neurol
DOI
EISSN
1531-8249
Publication Date
March 2020
Volume
87
Issue
3
Start / End Page
486
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Islet Amyloid Polypeptide
- Humans
- Diabetes Mellitus, Type 2
- Brain
- Amyloid
- Alzheimer Disease
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences